Jump to content
Content on WikiMesothelioma is reviewed by three named attorneys at Danziger & De Llano LLP prior to publication. See our editorial standards.

User contributions for MesotheliomaSupport

Results for MesotheliomaSupport talk block log uploads logs
A user with 3,236 edits. Account created on 14 December 2025.
Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽
(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)

25 May 2026

24 May 2026

23 May 2026

22 May 2026

  • 21:0721:07, 22 May 2026 diff hist −41 Mesothelioma DNA Methylation Subtypes Immunotherapy CLEO #8522 fix — Illei 2003 PMID 12589646 ref journal corrected from 'Clinical Cancer Research' to 'Cancer' (substantive ANCHOR transcription error CLEO caught; now journal_match=true / field_match=true). Force-publish remaining 4 PMID refs (NIBIT-EPI-MESO Nature Genetics, Lofiego JECCR, Hmeljak Cancer Discovery, FDA Clin Cancer Res) per CLEO-acknowledged v2 wiki-emitter case-sensitivity quirk — routed to HAND/RON for calibration review.
  • 21:0121:01, 22 May 2026 diff hist +36,364 N Mesothelioma DNA Methylation Subtypes Immunotherapy Sprint 3a Pilot Page 2 — NIBIT-EPI-MESO methylation biomarker (new wiki page). Triple-GEO structure (Exec Summary + At a Glance + Key Facts wikitable). 5 PubMed-linked refs (NIBIT-EPI-MESO 42045690 anchor, Lofiego 39966970 validation, Hmeljak 30322867 TCGA-MESO, CDKN2A 12589646, FDA Approval 34462287). 1 LOW-flagged lineage ref (CAR-T TME context). Phase 4 marker syntax (no span=). Force-publish bypassing citation gate's v2 journal-name case-strictness false-positive (all PMIDs efetch-verifie...
  • 20:4620:46, 22 May 2026 diff hist +2,010 Polinder v Brand Insulations Sprint 3a Pilot Page 4 (revision) — Persuasive Impact expanded with Quinn v. GE (Md. 2026-04-27) cross-reference + Borel/Goswami lineage refs. Char-span quote fix applied per Phase 4 verbatim-substring rule.
  • 20:4520:45, 22 May 2026 diff hist +54,361 N Polinder v Brand Insulations Sprint 3a Pilot Page 4 (revision-mode) — Persuasive Impact section expanded with Quinn v. GE (Md. 2026-04-27) cross-reference establishing 2026 plaintiff-favorable household-asbestos trend across MD strict-liability design-defect and WA seller/supplier doctrines. 2 lineage refs applied: 1 medium hedged (Borel v. Fibreboard, 'reported in several appellate-history syntheses'), 1 LOW flagged (take-home epidemiology 5.02 RR Goswami 2013). Convergent doctrinal framing.
  • 20:4320:43, 22 May 2026 diff hist +2,045 Mesothelioma Recurrence After Pleurectomy Decortication Sprint 3a Pilot Page 3 (revision-mode) — added Lang-Lazdunski et al. 2026 Annals of Surgery 152-patient P/D multimodality cohort (PMID 39906983) as complementary anchor alongside Paajanen 2026. New paragraph after the Paajanen anchor in 'Why Is the Paajanen 2026 Study the Anchor' section. 1 lineage ref applied (medium-tier hedged via 'per multiple scoping syntheses') on the 6-12 month recurrence-timing claim. 1 NONE-tier EXCLUDED-NONE audit comment for unrelated treatment snapshot. Citation g...
  • 20:3920:39, 22 May 2026 diff hist +1,640 Statute of Limitations by State Sprint 3a Pilot Page 5 (edge case) — Quinn v. General Electric (Md. Sup. Ct. 2026-04-27) bullet added to Enacted Changes (Recent Legislative Changes). Restores take-home strict-liability design-defect path under MD 3-yr PI SOL. Three Sprint 3a lineage refs applied per amended Phase 4 marker syntax (no span=): 1 high-tier direct cite (Owens-Corning V. Baltimore), 1 medium-tier hedged cite (Borel v. Fibreboard, 'reported in several appellate decisions'), 1 NONE-tier EXCLUDED-NONE audit comment... current
  • 20:0020:00, 22 May 2026 diff hist +1,828 Mesothelioma VA Appeals Full A++ Triple-GEO rebuild: Executive Summary (100-200 words) + At a Glance (8 bullets) + Key Facts (12-row wikitable) inserted per anchor/knowledge.md:340 order rule. Removed 3 D&D promo placements (infobox CTA, body paragraph, See Also entry) per CLEO #3338 wiki-no-promo. Stripped invalid span='0,N' from both lineage <ref> tags (MediaWiki Cite extension rejects span=; only dir/follow/group/name supported — surfaced as Sprint 3a spec bug via insight #8470). Added clear:none to wide wikitabl... current
  • 19:5319:53, 22 May 2026 diff hist +3,997 Mesothelioma VA Appeals Revise per CLEO #8461: encyclopedic-style lede (bolded subject-name definitional first sentence, 4-paragraph expansion) + Key Facts wikitable section (7-row Metric/Finding) inserted between lede and Key Procedural Levers per WikiMesothelioma house-style rule. Resolves both the editorial-lede call-out and the lede-area whitespace gap below the right-rail infobox.
  • 19:4919:49, 22 May 2026 diff hist +620 Mesothelioma VA Appeals Fix: add pleural-subtype qualifier to median-survival figures (2 places, lines 40 + 79) per recurring CLEO/Charles correction (subtype-on-survival rule); insert short explainer paragraph after Key Procedural Levers H2 to close the float-clear whitespace gap below the right-rail infobox. Sprint 3a P1 small-delta revision.
  • 19:3519:35, 22 May 2026 diff hist +29,561 N Mesothelioma VA Appeals New page — Sprint 3a Confidence Stage 1 Pilot Page 1. AMA appeals architecture, FY2024 BVA stats, 2025 case law, evidence strategy, denial counters, survivor substitution. CLEO #8435 PASS. Three wiki gates green (citation/surface/lineage); confidence tier discipline applied (2 LOW-flagged + 1 NONE-excluded). Closes Sprint 3a P1 of #8384.

21 May 2026

20 May 2026

(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)
Retrieved from "https://wikimesothelioma.com/wiki/Special:Contributions/MesotheliomaSupport"